LivPhcD® is a proprietary, science-backed Cordyceps sinensis mycelium (CS-4) ingredient developed by TCM Biotech through advanced large-scale fermentation technology. Standardized for key bioactive compounds, including adenosine and polysaccharides, LivPhcD® is designed to support liver health and metabolic wellness.
Backed by patented technologies and years of scientific research, LivPhcD® has been evaluated through preclinical and human clinical studies, with research focusing on liver function, hepatic fat accumulation, and metabolic health.
In 2026, results from our latest human clinical study on NAFLD (Non-Alcoholic Fatty Liver Disease) were accepted by the American Association for the Study of Liver Diseases (AASLD). The study abstract will also be presented at the AASLD 2026 Annual Meeting.
With growing scientific evidence and a strong foundation in fermentation biotechnology, LivPhcD® offers supplement and functional health brands a differentiated, clinically supported ingredient for next-generation liver and metabolic health formulations.
